Dystrophic myotonia type 1 (DM1) is a genetic neuromuscular disease, that affects several body systems. The clinical phenotype of patients with DM1 is highly variable, limiting early diagnosis and treatment. In the present study, we reported a 45-year-old female patient with DM1 with dyspnea as one of the prominent clinical manifestations, reviewed her family history, and reviewed the relevant literature. As a result, it turned out that the ability to determine the type and type of neuromuscular disease based on a correctly collected anamnesis, clinical and paraclinical research methods can reduce the time and costs of genetic research, and the awareness of non-neurological medical specialists about this disease contributes to early diagnosis, timely assistance and, thereby, improving the patient’s quality of life.
No takes yet. Share an insight, caveat, or question.
Shiraliyeva et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: